Eisai is a growing pharmaceutical company focused on satisfying unmet medical needs through innovative drug development with particular expertise in neurology and oncology. The company's human health care mission centers on increasing the benefits healthcare provides to patients, their families, and caregivers. Eisai is notable for developing the world's most widely-used treatment for Alzheimer's disease and has a strong emphasis on research and development. The company is expanding its pipeline in areas such as sleep disorders, including compounds in the orexin class for treating sleep-related conditions.
Beta · Sourced from candidate reports
Be the first to share your experience with Eisai.
Your reply helps other candidates know what to expect.
